Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
PledPharma CEO, Nicklas Westerholm
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
PledPharma / Pareto Securities’ 11th Annual Healthcare Conference
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
ActivePort Group success has "far exceeded expectations" | Paul van Heerwaarden, Technical Operations Manager, ActiveOps PLCAOM:LSE
00:10:00
Key Traits for a Successful Founding Team: Vision, Resilience, and Leadership
00:10:00
Unveiling the Future: Alan Pangborn on Chesapeake Gold's Promising Drilling Results and Upcoming Plans
00:10:00
AGCO CEO Eric Hansotia discusses rising grain prices driven by the conflict in Ukraine and its impact on agricultural markets with 'Mad Money' host Jim Cramer.|Eric P. Hansotia is Chairman, President, CEO & COO at AGCO Corp
00:10:00
Transforming Real Estate Portfolio Through Strategic Monetization and Asset Focus | John Albright, CEO, CTO Realty Growth Inc.
00:10:00
CEO Rosario Pingaro Unveils Convergenze’s Story, Values, and Ambitious Fiber Optic Project in Sapri | Rosario Pingaro, CEO, Convergenze SpA Società Benefit.
00:10:00
Northern Graphite Investor Event: Market Insights & Corporate Overview (Jan 18, 2024) | Hugues Jacquemin, Chief Executive Officer of Northern Graphite Corporation
00:10:00
Metals Australia Advances Lac Rainy Graphite Project| JON DUGDALE , Technical Advisor of Metals Australia Limited
00:10:00
Mastering the Art of Macro Investment Strategies: A Deep Dive into Global Economic Trends | Peter Hébert, Co-founder, Lux Capital.
00:10:00
Group 11 Resources: Advancing Zinc Exploration in Ireland
00:10:00
Maximizing Investment Potential: George Njunge - Senior Portfolio Manager at Britam Group
00:00:00
BBS's company presentation , Ilkka Kangasniemi, CEO, BBS-Bioactive Bone Substitutes